Ingredient explainer

Androstadienone

Also known as: AND; 4,16-androstadien-3-one; androsta-4,16-dien-3-one

Evidence: Mixed

A steroid derivative of testosterone found in male sweat and semen — the molecule with the strongest research signal for affecting women's mood and attention, though the strength of the effect remains debated.

What it is, structurally

Androstadienone (AND for short) is a 19-carbon steroid. It is a desaturated derivative of testosterone, with two double bonds added at the 4 and 16 positions of the backbone. It sits one or two enzymatic steps off the main androgen-metabolism map. On its own it carries no measurable hormonal activity.

The body makes it as a downstream metabolite of testosterone, mostly in the testes. It then secretes it through apocrine sweat glands. It concentrates in male armpit secretions and shows up in semen at meaningful levels. Women produce it too, in smaller amounts. The steady-state ratio runs roughly five-to-one, male over female.

On the nose, AND is less polarizing than its better-known cousin androstenone . Most people read it as a faint musky, slightly urinous note. It is closer to a soft skin musk than to anything aggressive. There is some individual variation, but nothing like the three-way split androstenone produces. That split runs sweet versus rotten versus anosmic, driven by the OR7D4 gene.

That makes AND easier to formulate around. A perfumer can include it without the bottle smelling completely different to one customer in three. With androstenone, roughly 30% are wired to find it offensive. AND does not carry that problem.

Why it's the most-studied human candidate

AND has produced the cleanest behavioral signal in human pheromone research. Human chemosignal work is thin and underfunded, so the pool it stands above is small. But the signal is real, and it keeps showing up. Three papers form the spine of the discussion.

Wyart et al. 2007 — the mechanism anchor

Wyart et al. 2007 ran in the Journal of Neuroscience. It is the molecular-mechanism anchor. The team showed that smelling AND shifted cortisol levels in women within fifteen minutes. It also produced distinct fMRI activation in regions tied to attention and emotional salience. Men showed neither effect. This is the paper people cite for proof AND does something real at the brain-chemistry level, before the messier question of behavior.

Saxton et al. 2008 — the real-world signal

Saxton et al. 2008 ran in Hormones and Behavior. It pushed the question into the real world. Women at a speed-dating event were exposed to AND or a clove-oil control between rounds. In the AND condition, women rated their male partners as more attractive than under control. The effect was modest but statistically significant. It remains the closest thing to a "works in the wild" data point the AND literature has.

Hare et al. 2017 — the counterweight

Hare et al. 2017 ran in Royal Society Open Science. It is the canonical counterweight. A larger, more tightly controlled replication tried to reproduce the Saxton-style effect on how women rate men's attractiveness. It could not find it. The team also tested estratetraenol, the proposed female counterpart, and found nothing. This is the paper skeptics like Tristram Wyatt point to when they argue the AND case is overstated. It is worth taking seriously, against a literature small enough for one null result to loom large.

So here is the honest summary. A real lab and fMRI signal from Wyart. A real social-context signal from Saxton. And a careful replication that did not find the attractiveness effect. Three data points, not a verdict. A handful of studies cannot close the case in either direction. What they show is a molecule that keeps registering, in a field that has barely been funded to look.

The Wyart fMRI finding

The Wyart 2007 paper is worth pulling out on its own. It sidesteps the behavioral-replication problem in a useful way. AND may not reliably swing whether a woman finds a man attractive in a noisy room. But it does measurably change brain activity. The fMRI work showed AND-driven activation in the anterior hypothalamus. It also lit up cortical regions tied to attention and salience processing. That pattern says the molecule is being detected and routed below conscious awareness, not just smelled and ignored.

The cortisol shift in the same paper points the same way. A few breaths of AND produced a hormonal response in women, not in men. The timescale was too short to be a mood the wearer talked herself into. So something is being processed, and there is a candidate route for it. The nervus terminalis, or cranial nerve zero, is a real nerve running from the nasal cavity to the forebrain, and some researchers propose it as a pathway for exactly this kind of chemosignal. That would let AND reach the brain without the working vomeronasal organ humans are often said to lack. What the processing turns into in real life is the open question. A flicker of attention, a small mood lift, or something a room notices before a word is spoken. Wyart shows the gate is open.

How women's products use it

Here is where AND's branding gets confusing. Men produce the molecule primarily, yet it shows up in plenty of women's pheromone products. There it works as a self-effect agent for the wearer, not as a signal aimed at an observer. The logic comes straight from Wyart. If AND lifts mood and sharpens attention in women, then putting it in a women's product is meant to do that for the woman wearing it. The copulin content in the same bottle is what aims at the male nose.

Men's products include AND too, for a different reason. It is part of the "this is what male skin actually smells like" framing. It gets layered alongside androstenone and androsterone in the standard male blend. So the same molecule does double duty depending on the bottle, and a good formula is clear about which job it is doing. The Athena Pheromones review covers the canonical women's formulation. The Pherazone review covers a men's product where AND is part of the stack.

How much makes a difference

This is the part nobody in the industry wants to talk about. Wyart's fMRI work used relatively high concentrations of AND. The dose was around 250 μM in a pentanol carrier, delivered directly under the nose in a controlled setting. Commercial perfumes use far less. They apply it to the skin, where the molecule has to evaporate, diffuse, and reach a nearby person at meaningful airborne concentration.

Whether commercial concentrations come close to the Wyart threshold is genuinely uncertain, and that is a real reason to shop carefully. Brands almost never disclose AND concentrations on the label. There is no standardization across the category. We cannot tell you whether your $50 cologne delivers one percent of what the published work used, or one hundredth of one percent. Dose is the variable that separates a bottle that does something from a scented placebo, and it is the one the market keeps hidden.

The honest verdict

Androstadienone has the best evidence base of any human pheromone candidate. That base is thin, because almost nobody has funded the work. But it points somewhere. A hormonal shift you can measure, brain activity you can image, a plausible route into the forebrain, and a real-world signal at a speed-dating table. The most careful replication missed the attractiveness effect, and that is worth keeping in view. If you are going to bet on one molecule mattering, this is the one. Just make sure the bottle actually carries a working dose of it.

For the broader honest take on the category, see do pheromone perfumes work . For the picks that actually include AND at meaningful-ish levels, see best pheromone perfumes for women and best pheromone perfumes for men .